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Abstract 
Background: Gametogenesis in mammals entails profound re‑patterning of the epigenome. In the female germline, 
DNA methylation is acquired late in oogenesis from an essentially unmethylated baseline and is established largely as 
a consequence of transcription events. Molecular and functional studies have shown that imprinted genes become 
methylated at different times during oocyte growth; however, little is known about the kinetics of methylation gain 
genome wide and the reasons for asynchrony in methylation at imprinted loci.
Results: Given the predominant role of transcription, we sought to investigate whether transcription timing is rate 
limiting for de novo methylation and determines the asynchrony of methylation events. Therefore, we generated 
genome‑wide methylation and transcriptome maps of size‑selected, growing oocytes to capture the onset and 
progression of methylation. We find that most sequence elements, including most classes of transposable elements, 
acquire methylation at similar rates overall. However, methylation of CpG islands (CGIs) is delayed compared with the 
genome average and there are reproducible differences amongst CGIs in onset of methylation. Although more highly 
transcribed genes acquire methylation earlier, the major transitions in the oocyte transcriptome occur well before the 
de novo methylation phase, indicating that transcription is generally not rate limiting in conferring permissiveness to 
DNA methylation. Instead, CGI methylation timing negatively correlates with enrichment for histone 3 lysine 4 (H3K4) 
methylation and dependence on the H3K4 demethylases KDM1A and KDM1B, implicating chromatin remodelling as 
a major determinant of methylation timing. We also identified differential enrichment of transcription factor binding 
motifs in CGIs acquiring methylation early or late in oocyte growth. By combining these parameters into multiple 
regression models, we were able to account for about a fifth of the variation in methylation timing of CGIs. Finally, we 
show that establishment of non‑CpG methylation, which is prevalent in fully grown oocytes, and methylation over 
non‑transcribed regions, are later events in oogenesis.
Conclusions: These results do not support a major role for transcriptional transitions in the time of onset of DNA 
methylation in the oocyte, but suggest a model in which sequences least dependent on chromatin remodelling are 
the earliest to become permissive for methylation.
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Background
The establishment of DNA methylation in the female 
germline in mammals is essential for genomic imprint-
ing and successful development of the embryo follow-
ing fertilisation [1–3]. Following genome-wide erasure 
of methylation in primordial germ cells [4], mammalian 
oocytes acquire a highly structured DNA methylation 
landscape in which domains of uniform methylation are 
separated by extensive unmethylated domains [5, 6]; this 
largely bimodal pattern is unique amongst mammalian 
cell types. DNA methylation is associated mostly with 
transcriptionally active gene bodies in oocytes, and these 
methylated domains contain intragenically located CpG 
islands (CGIs) that also gain methylation, including the 
germline differentially methylated regions (gDMRs) of 
imprinted genes [5–7]. As a result, there is highly pro-
grammed methylation of a defined set of ~2000 CGIs in 
oocytes, mostly on account of their location within active 
transcription units. We, and others, have shown that 
transcription is functionally required to define methyla-
tion in oocytes: Abrogating specific transcription events 
prevents methylation of the associated loci, including at 
imprinted gDMRs [6, 8, 9].
The oocyte represents a pure de novo methylation 
system, as an entire DNA methylation landscape is 
established on an essentially unmethylated genome in 
a non-dividing cell [10]; therefore, it provides a unique 
opportunity to investigate the extent to which differ-
ent sequence features acquire methylation as a result of 
common or distinct mechanisms. Current knowledge is 
largely limited to the fully established DNA methylome 
in fully grown oocytes at the germinal vesicle (GV) stage 
or in ovulated metaphase II (MII) oocytes [5, 11], such 
that differences in the mechanistic requirements for 
methylation of various sequence elements or in the kinet-
ics of their methylation are obscured. Thus, investigating 
methylation at intermediate stages would be informative, 
but genome-wide studies have not yet been done. Analy-
sis of a limited number of imprinted gDMRs identified 
that de novo methylation is a function of developmental 
stage of follicles and oocyte size, with methylation initi-
ated around the time follicles transition into the antral or 
secondary follicle stage of development. Moreover, locus-
specific analysis has shown that the onset and progres-
sion of methylation appear to differ between imprinted 
gDMRs [12–14]. This asynchrony has functional impor-
tance, as nuclear transfer experiments have shown that 
different imprinted domains acquire imprinting compe-
tence at different stages of oocyte growth [15].
In view of the rather simple methylation landscape of 
the oocyte, the differential timing of methylation acqui-
sition at gDMRs is unexpected, and the reasons for 
this asynchrony are unclear. Understanding its basis is 
essential for identifying the origin of methylation defects 
in oocytes that could underlie some errors in imprint-
ing. Such asynchrony also suggests that different fac-
tors, or combinations of factors, may be necessary for 
methylation of different gDMRs, individual CGIs or 
individual methylated domains, aside from the common 
requirement for the de novo DNA methyltransferase 
DNMT3A and its obligate partner DNMT3L [5, 7, 11]. 
Given the strong association with transcription [6], and 
major changes in the transcription programme during 
oocyte growth [16], one possibility is that the timings of 
transcription events traversing gDMRs and CGIs could 
account for differences in the onset of methylation at 
individual elements.
At a mechanistic level, de novo DNA methylation 
occurs in a chromatin template and, in accordance with 
the biochemical properties of DNMT3A and DNMT3L 
[17–19], is predicted to depend upon the acquisition of a 
permissive histone modification state. Thus, regions des-
tined for DNA methylation are proposed to be marked 
by histone 3 trimethylated at lysine 36 (H3K36me3) and 
should lack H3 di- or trimethylated at lysine 4 (H3K4me2/
me3) [7, 20]. Evidence in support of this model is the 
requirement for the H3K4 demethylase KDM1B for 
DNA methylation of most imprinted gDMRs and CGIs 
that acquire methylation in oocytes and the increase in 
H3K36me3 at these elements during oocyte growth [20, 
21]. Such chromatin state changes may also be down-
stream of transcription events: H3K36me3 is deposited by 
SETD2 in association with elongating RNA polymerase II 
[22–24], although the role of SETD2 in oocytes has not 
yet been determined; and removal of H3K4me2 and gain 
of H3K36me3 at the gDMR of the imprinted locus Zac1 
in oocytes was shown to depend on transcription from an 
upstream, oocyte-specific promoter [6].
To investigate how transcription influences the kinetics 
of methylation at gDMRs and throughout the genome, we 
generated genome-wide DNA methylation and high-res-
olution transcriptome maps of size-selected populations 
of growing oocytes spanning the onset of methylation. 
We find that the major remodelling of the oocyte tran-
scriptome occurs well before the onset of DNA methyla-
tion, indicating that initiation of transcription events is 
not temporally coupled to methylation of specific loci. 
However, rate of gene body methylation does correlate 
with transcription level, which could reflect the degree 
of transcription-coupled chromatin remodelling. CGI 
methylation timing reflects (1) the H3K4me2 levels found 
in non-growing and early growing oocytes, (2) depend-
ence on H3K4 demethylases and (3) presence of specific 
transcription factor motifs, supporting a model in which 
sequences requiring less chromatin remodelling are the 
earliest to become permissive for de novo methylation.
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Results
Capturing the onset of de novo DNA methylation 
in oocytes
To analyse the onset and progression of de novo methyla-
tion at a genome-wide scale, we isolated growing oocytes 
from pre-pubertal mouse ovaries (post-natal days 7–18) 
and sorted them into the following, non-overlapping 
size categories: 40–45, 50–55 and 60–65  μm. Genome-
wide methylation maps were generated by bisulphite 
conversion of oocyte DNA and Illumina sequencing. For 
unbiased genome coverage to enable interrogation of all 
sequence features in 60–65 μm oocytes, we applied post-
bisulphite adapter tagging (PBAT; [25]); for focussed cov-
erage of CGIs and other GC-rich sequences in all three 
size classes of oocytes, we applied reduced representation 
bisulphite sequencing (RRBS; [7]). The 60–65  μm PBAT 
library yielded 98,951,299 uniquely mapped read pairs, 
covering 18,651,142 (85.3%) of mappable CpG sites at 
≥1 read and 5,731,851 CpGs (26.3%) with ≥5 reads. The 
RRBS libraries covered between 551,677 and 838,372 CpG 
sites (≥5 reads) and 13,944–15,799 (60.6–68.7%) of the 
23,009 CGIs in the mouse autosomes and X chromosome 
(CGI coverage threshold ≥5 CpG sites with ≥5 reads; 
Additional file  1: Table S1). The PBAT and RRBS data 
were compared with published data sets from non-grow-
ing oocytes (NGO) and GV or MII oocytes [5, 7, 11]. In 
parallel, RNA sequencing (RNA-seq) libraries were made 
from similar pools of size-selected oocytes (see below).
The overall CpG methylation level of 60–65  μm 
oocytes determined by PBAT was 22.25%, compared 
with 2.36% in NGOs and 38.68% in GV oocytes, show-
ing that this stage represents a midpoint in the progres-
sion of global de novo methylation (Fig.  1a; Additional 
file 2: Table S2). We then evaluated whether all genomic 
features that become methylated in GV oocytes gain 
methylation at similar rates, including the hypermethyl-
ated domains of GV oocytes we previously designated 
[6]. CpGs in hypermethylated domains have attained on 
average 48.00 ± 0.02% methylation in 60–65 μm oocytes 
(Additional file  2: Table S2), although there is a consid-
erable spread in the methylation level of these CpGs at 
this time (Fig.  1b). We previously showed that 85–90% 
of hypermethylated domains were associated with tran-
scription units active in oocytes [6]; therefore, we asked 
whether domains associated with transcription units and 
those apparently not associated with transcription dis-
played similar kinetics of methylation. Comparison of 
CpG methylation rate of transcribed hypermethylated 
domains and apparently transcriptionally silent hyper-
methylated domains revealed that CpGs in transcrip-
tionally silent regions are methylated later: average CpG 
methylation in transcribed domains is 50.1% but 30.0% 
for transcriptionally silent regions (Fig. 1b). For CGIs that 
become methylated fully (≥75%) in GV oocytes, mean 
methylation (37.21  ±  0.69%) in 60–65  μm oocytes was 
less than most other sequence features (Fig.  1b; Addi-
tional file  2: Table S2). An effect of CpG density is also 
apparent when considering 2-kb genomic windows: 
regions of highest methylation (≥80%) in 60–65  μm 
oocytes had on average lower CpG density and GC con-
tent (Fig. 1c).
Similar to hypermethylated domains, most classes of 
transposable element (TEs) that become methylated 
(≥75%) in GV oocytes are midway in methylation pro-
gression (Fig.  1b; Additional file  2: Table S2, Additional 
file  3: Fig. S1A), although there was interesting varia-
tion in the kinetics of specific elements. Some TEs start 
at a higher level of methylation in NGOs, such as some 
endogenous retroviral (ERVK) long-terminal repeat 
(LTR) elements, reflecting incomplete erasure of methyl-
ation in primordial germ cells [4]. In addition, there was a 
significant variation in the rate of methylation of specific 
TE subfamilies. Notably, of the 20 most abundant LINE-
L1 subfamilies, methylation of three of the four L1Md 
subfamilies was significantly delayed (average methyla-
tion of L1Md_A 39.9%, L1Md_F3 44.3% and L1Md_T 
42.0%, compared with 48.1–54.4% for the remaining L1 
subfamilies). In comparison, there were no differences in 
the methylation rate of the 20 MaLR subfamilies (Addi-
tional file  3: Fig. S1B). L1Md elements are amongst the 
youngest L1s, with the least degenerated sequence, the 
most intact transcription factor (TF) binding sites and 
which have to be actively suppressed [26, 27]. Many of 
the L1Md subfamilies also retained residual methylation 
in NGOs (6.5–19.9%, compared with 1.4–3.7% for other 
L1s). These results indicate that different sequence fea-
tures acquire methylation with similar overall kinetics, 
suggesting that the de novo methylation complex is not 
targeted preferentially to any particular sequence feature. 
However, the delayed methylation of CGIs and specific 
L1 subfamilies, as well as at untranscribed regions, points 
to additional or alternative mechanistic requirements at 
these elements.
In fully grown oocytes, there is a high level of con-
cordance in methylation of adjacent CpGs across the 
extensive hypermethylated domains [6]. Having cap-
tured oocytes midway in the progression of methyla-
tion, we looked at the coherence of ongoing methylation 
to investigate co-operativity of the de novo methylation 
complex. For each sequencing read containing multiple 
CpGs, we asked how often and over what distance CpGs 
had the same methylation state. For 60–65 μm oocytes, 
neighbouring CpGs were both methylated 60–70% of 
the time over 60  bp and at least 50% of the time over 
90 bp (Fig. 2a). If CpG sites were being methylated indi-
vidually without co-operativity, the probability that CpG 
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pairs were both methylated would equate to the overall 
genomic methylation level which, in 60–65 μm oocytes, 
was 17.56%. Therefore, these data indicate co-operativity 
in methylation of adjacent CpGs by DNMT3A/DNMT3L 
during oocyte growth, similar to findings of DNMT3B 
function in embryonic stem cell (ESC) [28]. We note, 
also, that although concordance of methylation declines 
with distance, there is a local maximum in the correla-
tion at ~180  bp (Fig.  2b), which approximates the size 
of a nucleosome, consistent with a model in which de 
novo methylation occurs in linker regions, as proposed 
in ESCs [28]. Finally, oocytes have been shown to have 
extensive methylation outside of the CpG context, in that 
methylation of non-CpG sites accounts for more than 
half of the total amount of methylated cytosine [11, 29]. 
We looked specifically at all informative cytosines that 
become fully methylated (≥75%) in GV oocytes. Strik-
ingly, in 60–65 μm oocytes, CHG and CHH sites (where 
H = A, T or C) that become methylated in GV oocytes 
were only 10.77 ±  0.08 and 13.90 ±  0.05% methylated, 
respectively, compared with 49.31 ± 0.05% for CpG sites, 
indicating preferential methylation of CpG sites during 
oocyte development (Fig. 1d; Additional file 4: Table S3).
CGIs and imprinted gDMRs gain DNA methylation 
at different rates in oocytes
To look in more detail at the progression of methylation 
at CGIs, we considered the RRBS datasets. There is very 
little methylation of CGIs in 40–45  μm oocytes: only 
three CGIs (of 522 CGIs with sufficient data) that become 
fully methylated in GV oocytes were methylated ≥25% 
in 40–45  μm oocytes, and two of these have residual 
(See figure on previous page.) 
Fig. 1 Rates of de novo DNA methylation of different sequence features in growing oocytes. a Screenshot of a 2.3‑Mb interval of chromosome 1 
depicting methylation in NGOs, 60–65 µm and GV oocytes. Vertical bars represent mean methylation of 2‑kb windows, with 1‑kb steps, height and 
colour denoting % methylation. The horizontal lines are set at 50% methylation, with higher levels of methylation above the line and lower levels 
below the line and shaded according to the colour scale on the left. The 60–65 µm data are from PBAT from the current manuscript; NGO and GV 
data are from [5, 11]. b Violin plots showing distribution of CpG methylation values in all hypermethylated domains, transcribed hypermethylated 
domains (≥90% of the length of the domain covered by transcript, domains ≥5 kb), transcriptionally silent hypermethylated domains (≤10% of the 
length of the domain covered by transcript, domains ≥5 kb), CGIs, LINE L1s and SINE‑B2s in NGO, 60–65 µm and GV oocytes. Shape of the violin plot 
represents Kernel density estimation, i.e. probability density of the data at the different values. White dots correspond to the median, yellow dots to 
the average, bold lines the interquartile range and thin lines adjacent values, i.e. minimum and maximum values within the ×1.5 interquartile range 
from the first and third quartile, respectively. c Box whisker plots reporting CpG density and GC content of 2‑kb genomic regions that are fully meth‑
ylated in GV oocytes (≥75% DNA methylation) categorised according to their % DNA methylation in 60–65 µm oocytes (x axis). Boxes, interquartile 
range, with bar as median and whiskers as ×1.5 interquartile range, outliers not shown. Between 3619 and 30320 2‑kb intervals were analysed in 
each methylation category. d Violin plots showing methylation levels of Cs in CpG, CHG and CHH contexts in NGOs and 60–65 µm oocytes of Cs 
that are fully methylated (≥75%) in GV oocytes
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Fig. 2 Properties of ongoing de novo DNA methylation in growing oocytes. a Average proportion of neighbouring CpG pairs where both CpGs 
are methylated (M–M fraction) by distance of CpG pairs in NGO, 60–65 µm and GV oocytes. The value of the M–M fraction was quantified for each 
possible distance between two neighbouring CpGs on the same sequencing read using formula M–M pairs/(M–M + M–U pairs), where M–U pairs 
represent CpG pairs where upstream CpG is methylated and downstream unmethylated. Only reads mapping to chromosome 1 were analysed. The 
horizontal lines represent the genomic average methylation level of each stage. b The distant‑dependent correlation of methylation between CpG 
pairs in 60–65 µm oocytes, compared with random‑shuffled data
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methylation in NGOs [7]. Methylation was first detected 
in the 50–55 μm size class (22% of CGIs destined for full 
methylation having ≥25% methylation in this size group) 
and at least 55% of CGIs showed intermediate (25–75%) 
to high (≥75%) levels of methylation in 60–65 μm oocytes 
(Fig. 3a). Overall, there was a very high level of correla-
tion (R = 0.929) between the RRBS and PBAT libraries in 
CGI methylation at the 60–65 μm stage (Additional file 3: 
Fig. S2A), suggesting that the differences in level of meth-
ylation are reproducible and biological in origin. Focus-
sing on imprinted gDMRs, methylation in 60–65  μm 
oocytes assessed by the two methods ranged from 0 to 
~70% (Fig.  3b; Additional file  3: Fig. S2A), again with a 
high degree of consistency in methylation of individual 
gDMRs determined by the two methods (noting that 
RRBS and PBAT will not have identical sequence cover-
age across each gDMR). For example, the Igf2r gDMR 
had attained 32.5% methylation in 50–55  μm oocytes 
and 67.9% in 60–65 μm oocytes, while the Cdh15 igDMR 
was <5% methylated even in 60–65 μm oocytes (Fig. 3b). 
This range of methylation is broadly consistent with ear-
lier studies that analysed limited numbers of gDMRs by 
locus-specific bisulphite sequencing (again, with the 
caveat that different regions of the gDMRs will have been 
assayed by the various methods; [12–14]). For a subset of 
CGIs, we also validated the time of onset by locus-spe-
cific bisulphite sequencing (Fig. 3c). The differential onset 
of CGI methylation is not related to CpG content or GC 
richness of these CGIs (Additional file  3: Fig. S2B). In 
conclusion, CGIs destined for methylation in GV oocytes 
are not co-ordinately methylated but display substantial 
and reproducible differences in time of onset of methyla-
tion in growing oocytes, and this variation is not a simple 
property of overall sequence composition.
Mapping changes in the oocyte transcriptome 
during oocyte growth
We sought to test the relationship between methyla-
tion kinetics and changes in transcription during oocyte 
development and growth. To do so, we generated deep, 
strand-specific total RNA-seq libraries in duplicate from 
the same size populations of growing oocytes as used 
in methylation analysis, as well as an earlier population 
(10–30 μm) and a GV population (Additional file 5: Table 
S4). In addition, the data were compared with RNA-seq 
from NGOs collected at embryonic day E18.5 [20] and 
an existing GV data set [6]. Although transcriptional 
changes have been documented during mouse oocyte 
development before [16], those data were generated 
using expression microarrays that capture only a frac-
tion of the transcription units actually present in oocytes 
and cannot be used to infer alternative transcription start 
site (TSS) use: our previous work has demonstrated the 
importance of using the correct transcriptome for accu-
rate association with methylation [6]. Although the RNA-
seq data sets do not capture nascent transcription events, 
they do enable us to determine the time during oocyte 
growth that transcription units are first active, including 
the use of alternative upstream TSSs that are prevalent 
in oocytes [6]. Transcript abundance was used as a proxy 
for transcription rate.
The RNA-seq data sets were compared with the oocyte 
transcriptome assembly previously generated in our lab-
oratory [6], resulting in the detection of 21,402–32,775 
genes (FPKM thresholds 0.017–0.102) in the various 
oocyte size populations (Additional file  6: Table S5). 
Principal component (PC) analysis of the global expres-
sion patterns showed that data sets from growing and 
GV oocytes cluster together, with the E18.5 transcrip-
tome being the most distinct; PC2 segregates the grow-
ing oocyte populations by size, particularly when the 
E18.5 data set is excluded (Additional file  3: Fig. S3). It 
should be noted that E18.5 oocytes were collected using 
FACS, such that RNA was extracted from fixed samples, 
whereas all post-natal oocytes were collected manu-
ally, and these technical differences could contribute to 
some differences between the E18.5 transcriptome and 
the other stages. Nevertheless, most transcripts (68%) 
were already detected at E18.5, and a further 28% were 
detected first in 10–30 µm oocytes, with very few appear-
ing for the first time in larger size populations (Fig. 4a). 
The general stability of gene expression in the growing 
oocyte populations, even as cytoplasmic volume and 
mRNA content are increasing substantially, is reflected 
in the rather small numbers of genes identified as dif-
ferentially expressed (<4%) between consecutive stages 
(Additional file 3: Fig. S4). Based on our oocyte transcrip-
tome assembly, we segregated genes into reference genes 
(i.e. previously annotated genes) and novel genes, either 
novel multiexonic or monoexonic. For reference genes 
expressed from their canonical TSSs, 88% were already 
detected at E18.5; in comparison, most novel genes were 
detected first in 10–30  µm oocytes (~63% multi- and 
~57% monoexonic novel genes), with a small minority 
first detected in larger oocytes (~8 and ~13% for multi- 
and monoexonic genes, respectively; Fig.  4a). Similarly, 
most (~70%) novel upstream TSSs were activated in 
10–30 µm oocytes. Therefore, most changes in the oocyte 
transcriptome occur well in advance of the onset of de 
novo methylation, which initiates after the 40–45  µm 
stage. This effect can be seen at individual imprinted loci: 
all gDMRs are found within transcription units even at 
the earlier stages, irrespective of whether they are tran-
scribed from alternative promoters or whether methyla-
tion is detected early (50–55 µm) or late in oocyte growth 
(60–65 µm) (Fig. 4b).
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Despite the general stability of gene expression dur-
ing oocyte growth stages (Additional file  3: Fig. S4), the 
RNA-seq data sets provide unprecedented detail into the 
changes in transcript abundance during critical times in 
oocyte growth and follicular differentiation. We identified 
530 genes, mostly protein-coding, up-regulated greater 
than 50-fold between E18.5 and GV oocytes, and 283 up-
regulated >50-fold between E18.5 and 10–30 μm oocytes 
(Additional file  7: Table S6). Gene ontology (GO) analy-
sis did not reveal particularly strong enrichment terms 
(“Regulation of reproductive process” containing 10 of 
the 283 genes had the highest enrichment of 5.53, p value 
1.27 × 10−5, adjusted FDR 0.164), perhaps reflecting the 
wide diversity of functions required during oogenesis as 
well as the accumulation of maternal RNA stores for pro-
cesses in the zygote (Additional file 3: Fig. S5). The set of 
highly induced transcripts did contain genes for oocyte-
specific transcriptional regulators such as OBOX1, 2 and 
5, the maternal effect homeobox SEBOX, the zona pellu-
cida proteins 1, 2 and 3 (ZP1, 2, 3), components of the sub-
cortical maternal complex (OOEP, TLE6) and members of 
the reproduction-related NLRP family (nucleotide-bind-
ing oligomerization domain, leucine-rich repeat and pyrin 
domain-containing proteins), as well as oocyte genes 
with less well explored functions (Oas1d, Oosp1, Omt2b) 
(Additional file  7: Table S6). We also specifically exam-
ined the gene expression dynamics of candidate factors 
involved in de novo DNA methylation and associated epi-
genetic modifications, such as DNMT3A and DNMT3L, 
H3K4 demethylases of the KDM1 and KDM5 families, 
and the H3K36 methyltransferase SETD2. Although many 
of the corresponding genes appear to be stably expressed 
during oocyte growth, there was substantial up-regulation 
of Kdm1b, Dnmt1 and particularly Dnmt3L, whose tran-
scripts appear first in 10–30 μm oocytes (Additional file 3: 
Fig. S6). These transcript dynamics are consistent with the 
reported appearance of KDM1B and DNMT3L proteins 
during oocyte growth [21, 30].
DNA methylation kinetics in relation to transcription 
events
Although the global results above do not support a 
major role for activation of specific transcription units 
in the timing of de novo methylation, we performed 
several additional analyses to investigate in more detail 
possible relationships between transcription events 
and temporal control of methylation. We compared 
the methylation level of multiexonic reference genes 
and multiexonic novel genes, reasoning that the refer-
ence genes are generally expressed from earlier time 
points in oocyte growth (Fig.  4a). For this, we selected 
genes ≥4  kb in length (as shorter genes are unmethyl-
ated across much of their length) and set an expression 
threshold of ≥2 FPKM (to mitigate an effect of expres-
sion level). In this comparison, reference genes as a 
set have accumulated more methylation in 60–65  µm 
oocytes (Fig. 5a). Level of expression could still contrib-
ute to this effect, as novel genes are less highly expressed 
[6]: for the genes we included above 2 FPKM, median 
FPKM values were 11.4 and 3.9 for reference and novel 
genes, respectively. Indeed, there was a positive corre-
lation between gene body methylation and expression 
level in 60–65  µm oocytes, particularly for reference 
genes, although the relationship plateaus for more highly 
methylated gene bodies (Fig.  5b). We also considered 
whether genes exceeding an expression threshold earlier 
during oocyte growth acquire methylation sooner, and 
this appeared to be the case (Fig.  5c). Again, however, 
it is difficult to separate out an effect of gene expres-
sion level, as genes crossing the threshold earlier are also 
more highly expressed in 60–65 µm oocytes (Fig. 5d). An 
effect on host gene expression was apparent for intra-
genic CGIs that gain methylation during oocyte growth, 
although the differences between groups were not sig-
nificant (Fig. 5e). We also examined whether the extent 
of methylation of these CGIs in 60–65  µm oocytes 
reflected whether they were active TSSs at an earlier 
stage (E18.5 NGOs). Indeed, CGIs previously acting as 
TSSs had gained less methylation on average than non-
TSS-CGIs (Fig.  5f ). This analysis was performed with 
the PBAT data set, as RRBS data have limited coverage 
of gene bodies. When we compared DNA methylation of 
intragenic CGIs in 50–55 and 60–65 µm RRBS data sets 
with expression levels of overlapping genes in the corre-
sponding RNA-seq datasets, we obtained similar results 
to the PBAT data (Additional file 3: Fig. S7).
(See figure on previous page.) 
Fig. 3 CpG islands gain DNA methylation at different rates in growing oocytes. a Barchart of CGI methylation in the oocyte size populations from 
the RRBS and PBAT datasets. The number of CGIs covered in each dataset is given in Additional file 1: Table S1. b Methylation of gDMRs in RRBS 
datasets, displaying the basal level in 40–45 µm oocytes, and the increases in methylation to the subsequent size populations. gDMRs are ordered 
according to their methylation level in 60–65 µm oocytes, which is comparable with PBAT data (see Additional file 3: Fig. S2A). c Validation of CGI 
methylation in different oocyte size populations. Heatmap shows methylation progression at CGIs that become methylated between 40 and 45 µm 
and MII oocytes (data from published GV and MII RRBS datasets). Five early‑methylating CGIs and five late‑methylating CGIs were selected, and 
their methylation in 50–55 µm oocytes (early‑methylating CGIs) or both 50–55 and 60–65 µm oocytes was confirmed by locus‑specific bisulphite 
sequencing. White dots represent unmethylated CpGs and black dots methylated CpGs
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Changes in TSS use could reflect changes in bind-
ing of sequence-specific TFs at these sites, possibly as 
a consequence of down- or up-regulation of these fac-
tors during oocyte growth. In this context, it has previ-
ously been reported that the CGCGC consensus site of 
E2F1 and E2F2 is enriched in intragenic CGIs that are 
completely resistant to de novo methylation in oocytes 
[31]. Accordingly, we used the motif analysis package 
DREME [32] to identify motifs differentially enriched in 
CGIs with different levels of methylation in 60–65  µm 
oocytes. We searched for motifs enriched in late-methyl-
ated CGIs (≤25%) compared to CGIs with 25–50, 50–75 
and ≥75% methylation, as well as for motifs enriched in 
early-methylated CGIs (≥75 and 50–75% methylation) 
compared to late-methylated CGIs (Fig. 6a). There were 
no motifs enriched in early-methylated CGIs compared 
to CGIs gaining methylation later, suggesting that there 
is no sequence motif targeting methylation to specific 
CGIs. On the other hand, we found motifs significantly 
enriched in late-methylated CGIs. Considering the com-
parison between ≥75% methylated and ≤25% methylated 
CGIs as likely to give the greatest discriminating signal, 
there were 21 sequence motifs with a significant differ-
ence in enrichment, three of which correspond to binding 
sites of known TFs (Fig. 6b; Additional file 8: Table S7). 
Of these, the most significant motif C(C/G/T)CCGCC 
(p value = 7.4 × 10−13) was detected in 55% of the late-
methylating CGIs but only 9.5% of the early-methylating 
CGIs. We repeated the analysis with the MEME motif 
analysis package [33] to search for longer motifs than 
DREME. Again, the significantly enriched motifs were 
found only in late-methylated CGIs compared to CGIs 
with methylation of 50–75 and ≥75%. Late-methylated 
CGIs appear to be enriched in G-rich motifs; however, 
these motifs are also present in 50% or more of the early-
methylating CGIs (Additional file 3: Fig. S8).
CGI methylation in relation to chromatin state
Since transcription does not appear to be an over-
riding factor in the differential timing of CGI meth-
ylation, we examined the influence of specific histone 
post-translational modifications, given the likely 
importance of chromatin state in recruitment of the 
DNMT3A:DNMT3L complex. We divided CGIs that 
become fully methylated (≥75%) in GV oocytes into 
levels of methylation attained in 60–65  μm oocytes 
and assessed the enrichment of histone modifications 
as determined by chromatin immunoprecipitation and 
sequencing (ChIP-seq) in NGOs (isolated at E18.5) and 
early growing oocytes (post-natal day p10) [20]. Of the 
modifications implicated in promoting or antagonising 
DNA methylation, levels of H3K36me3 showed a posi-
tive correlation with DNA methylation level; H3K4me2 
and H3K4me3, conversely, were negatively corre-
lated (Fig. 7a, all p values <1 × 10−10). We then looked 
whether there was a relationship with dependence on 
the H3K4me2 demethylases KDM1A and KDM1B. We 
have previously shown that loss of KDM1B, in par-
ticular, affects the methylation level acquired in MII 
oocytes of many CGIs, but there is a considerable vari-
ation in the magnitude of the dependency [20]. There-
fore, we compared the change in DNA methylation of 
CGIs in oocytes deficient in KDM1A or KDM1B with 
level of methylation in wild-type, 60–65  μm oocytes, 
which showed that later-methylating CGIs (i.e. less 
methylation in 60–65 μm oocytes) are most dependent 
on KDM1A or KDM1B to become fully methylated in 
MII oocytes (Fig. 7b). Examples of early- and late-meth-
ylating CGIs in relation to H3K4me2 level and KDM1B 
dependence are shown in Fig. 7c.
Modelling factors determining rate of CGI methylation
To test the extent to which the above variables, alone 
or in combination, account for the differential timing of 
CGI methylation in growing oocytes, we applied several 
regression models. We considered up to nine independ-
ent variables, including the three transcription factor 
binding motifs significantly enriched in the late-methyl-
ating CGIs (Table 1), with methylation level in 60–65 µm 
oocytes as response variable. As all the variables except 
GC content are in statistically significant linear relation-
ship with the response variable, we first tested how much 
of the methylation variation could be attributed to each 
of the variables alone in simple linear regression mod-
els. H3K4me2 enrichment at p10 and dependence on 
KDM1B and KDM1A explained the highest proportion 
of the variability in the methylation data: 11.2, 10.5 and 
9.7%, respectively.
(See figure on previous page.) 
Fig. 4 Transcription dynamics in growing oocytes. a Barchart showing time of first detection of genes in growing oocytes, according to classifica‑
tion as reference gene, from canonical TSS (w/o upTSS) or novel upstream TSS (upTSS), or novel multi‑ or monoexonic gene. The total numbers 
of genes classified as expressed in each RNA‑seq datasets are given in Additional file 6: Table S5. b Browser screenshots of representative early‑
methylating (Igf2r, Zac1) and late‑methylating (Cdh15, Nnat) gDMRs in relation to RNA‑seq data from different stages of the oocyte growth and 
DNA methylation acquired in 60–65 µm oocytes. In the RNA annotation track, red gene structures are transcribed from left to right and blue gene 
structures from right to left, with arrows showing the most upstream TSSs and direction of transcription. RNA‑seq data show that transcriptional pat‑
tern is established prior to DNA methylation establishment
Page 11 of 19Gahurova et al. Epigenetics & Chromatin  (2017) 10:25 
D
N
A
 m
et
hy
la
ti
on
 (
%
) 100
80
60
40
20
0
reference genes novel genesa
0 0.2 0.4 0.6 0.8 1
proportion of genes
0-25%
25-50%
50-75%
75-100%
DNA methylation
0.0
0.5
1.0
1.5
2.0
2.5
3.0
lo
g 
(F
PK
M
+
1)
0-25%
25-50%
50-75%
75-100%
reference genes novel genesb
0%
20%
40%
60%
80%
100%
noitalyhte
m 
A
N
D
f
TSSno 
TSS
0-25%
25-50%
50-75%
75-100%
DNA methylation
0.0
0.5
1.0
1.5
2.0
2.5
3.0
lo
g 
(F
PK
M
+
1)
e CGIs
n.s. n.s. n.s. *
* n.s. n.s.*** n.s.***
0
20
40
60
80
100 noitalyhte
m 
A
N
D 
%
   setycoo 
mµ 56-06 ni
10-30
µm 40-45
µm
50-55
µm 60-65
µm
GV
never
FPKM > 1
c
0
0.5
1
1.5
2
2.5
3
 )1
+
M
KPF( gol
  setycoo 
mµ 56-06 ni
10-30
µm
40-45
µm
50-55
µm
60-65
µm
GV
never
FPKM > 1
d
Page 12 of 19Gahurova et al. Epigenetics & Chromatin  (2017) 10:25 
(See figure on previous page.) 
Fig. 5 Gene body and CpG island methylation kinetics in relation to transcription. a Cumulative distribution plot of methylation level of reference 
and novel genes (≥4 kb in length and ≥2 FPKM) in 60–65 µm oocytes (PBAT dataset). The numbers of reference and novel genes satisfying the 
criteria for analysis were 105 and 32, respectively. b Box whisker plots of methylation of gene bodies of reference (1396) and novel (373) genes in 
relation to expression level in 60–65 µm oocytes. c Box whisker plot showing methylation level of CGIs in 60–65 µm oocytes grouped according 
to the stage in oocyte growth that expression of overlapping gene attained the threshold of >1 FPKM in the RNA‑seq datasets. d Box whisker plot 
showing the corresponding data from expression level in 60–65 µm oocytes. The numbers of genes in (c) and (d) are: 1013 for 10–30 µm oocytes, 
76 for 40–45 µm, 70 for 50–55 µm, 47 for 60–65 µm, 57 for GV and never 289. e Methylation level of intragenic CGIs (CGIs fully methylated in GV 
oocytes) in relation to expression level of the corresponding gene in 60–65 µm oocytes. The numbers of CGIs analysed in each methylation cat‑
egory (from lowest to highest) are: 269, 210, 281 and 50. f Methylation in 60–65 µm oocytes of CGIs (CGIs fully methylated in GV oocytes) according 
to prior activity as TSS as determined in e18.5 oocytes: 112 TSS‑CGIs and 1229 non‑TSS‑CGIs. Asterisks denote p values of Student’s t test: *0.01–0.001, 
**0.001–0.0001, ***<0.0001
Because of the multicollinearity amongst independ-
ent variables (e.g. high correlation between transcription 
level and H3K36me3 enrichment, or between H3K4me2 
and H3K4me3 enrichments), we could not test the 
combination of all variables in a classical multiple lin-
ear regression model. Instead, we applied linear model-
ling approaches correcting for multicollinearity—Ridge, 
Lasso and ElasticNet regressions—and looked for the 
best fit. Lasso and ElasticNet regression models using all 
nine variables explain 23.14% of the variability (Fig.  8). 
However, the cross-validation of models, where indi-
vidual independent variables are added one by one to 
the model, in each step adding the variable that explains 
the highest proportion of the variability, revealed that 
Analysis No of motifs with DREME E-value ≤ 0.05 Motifs with Tomtom Q-value ≤
0-25 vs 25-50 0 0
0-25 vs 50-75 15 4
0-25 vs 75-100 21 3
50-75 vs 0-25 0 0
75-100 vs 0-25 0 0
a
Unerased
E-value
CBCCGCC 7.4x10-13 3.3x10-8 2.1x10-8
EGR1/2i Smad3i Bcl6bi SP1/2i
CH4i Zfp410i Klf4/7/5i ERF1i
Ascl2i SUT1i MIG2/3i UGA3i
NHP10
CCCMAM 2.7x10-11 0.0000012 5.8x10-7 ADR1i YPR022C
CBCCGGG 8x10-9 0.00033 0.000097 Zic1/2/3i SIP4
b
Motif Logo P-value E-value
Binding sites of known
TFs
Fig. 6 Motifs differentially enriched in early‑ and late‑methylating CpG islands. a Summary of results of DREME analysis identifying motifs dif‑
ferentially enriched in CGIs that become fully methylated in GV oocytes grouped according to methylation level in 60–65 µm oocytes. Codes 0–25, 
25–50, 50–75 and 75–100 represent CGIs with corresponding percentage methylation in 60–65 µm oocytes. The numbers of CGIs in each category 
are 470, 329, 384 and 63, respectively. b DREME motifs significantly enriched in CGIs methylated ≤25% in oocytes compared with ≥75% methyl‑
ated CGIs that correspond to binding site motifs for known TFs. In motif sequence, B = C/G/T and M = C/A. P value and E values are as defined by 
DREME and binding sites as identified by Tomtom
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Table 1 Linear regression models explaining DNA methylation level at CGIs in 60–65 µm oocytes
Simple linear regressions (variables tested individually) and multiple linear regression (variables tested together) modelling the relationship between explanatory 
variables and DNA methylation level at CGIs in 60–65 µm oocytes. The outcome of the model is presented as a proportion of the variability in DNA methylation level at 
CGIs in 60–65 µm oocytes explained by the variables
a See Fig. 6a for motifs details. These three motifs were selected as they represent binding sites of known proteins
b Coefficients of variables in the model selected after software cross-validation of models as the most regularised model. These coefficients correspond to the values 
on y axis in Fig. 8. N/A marks variables that are not included in the model
c The Lasso regression model including the 5 variables indicated in the column accounts for 18.5% of the variation
Variable Simple linear regression Lasso regression
Significance (p value) % variability explained Coefficient value in the most regularised 
 modelb, c
H3K4me3 enrichment, p10 ChIP‑seq 2.34 × 10−6 4.8 N/A
H3K4me2 enrichment, p10 ChIP‑seq 2.88 × 10−13 11.2 −0.132
H3K36me3 enrichment, p10 ChIP‑seq 8.21 × 10−8 6.2 0.050
KDM1A dependence 1.1 × 10−11 9.7 −0.132
KDM1B dependence 1.5 × 10−12 10.5 −0.106
CpG density 0.000767 2.5 N/A
%GC content 0.169199 0.9 N/A
Transcription level (log‑transformed) 0.000297 2.9 N/A
Enriched motif occurences (CBCCGCC, CCCMAM, 
 CBCCGGGa)
3.97 × 10−8 6.5 −0.019
Fig. 8 Modelling factors determining rate of CpG island methylation. Lasso regression model plot showing the effect of nine independent variables 
on variability of CGI methylation in 60–65 µm oocytes. Each line represents one of the variables. The earlier the line deviates from the horizontal 
line with coefficient 0.0, the more the corresponding variable contributes to the variability of the response variable, and the steeper the slope the 
greater the effect. If the steepness of the slope of one variable already in the model changes when a new variable comes into the model, it is a sign 
of correlation between two independent variables
(See figure on previous page.) 
Fig. 7 CpG island methylation kinetics in relation to chromatin parameters. a Box whisker plots showing enrichment (log‑transformed corrected 
read count) of H3K4me2, H3K4me3 and H3K36me3 at CGIs in relation to DNA methylation in 60–65 µm oocytes (PBAT data). The ChIP‑seq data 
shown are from p10 oocytes; similar trends were observed in ChIP‑seq data from e18.5 oocytes. Pearson’s correlation coefficients are: −0.293 for 
H3K4me2, −0.173 for H3K4me3, 0.240 for H3K36me3. The numbers of CGIs analysed in each methylation category (from lowest to highest) were: 
464, 327, 382 and 63. b Box whisker plots showing the degree of DNA methylation change at CGIs in Kdm1a‑ and Kdm1b‑null MII oocytes in relation 
to methylation in 60–65 µm oocytes. Pearson’s correlation coefficients are: −0.296 for Kdm1a and −0.357 for Kdm1b. The numbers of CGIs analysed 
in each methylation category (from lowest to highest) were: 244, 185, 255 and 28 for Kdm1a, and 270, 199, 268 and 31 for Kdm1b. c Browser screen‑
shots of a representative early‑methylating and late‑methylating CGI (84.2 and 12.2% methylation in 60–65 µm oocytes, respectively) in relation to 
p10 H3K4me2 enrichment and DNA methylation attained in wild‑type (WT) or Kdm1b‑null MII oocytes
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H3K4me2 enrichment, KDM1A and KDM1B depend-
ency, H3K36me3 enrichment and the presence of TF 
binding motifs are sufficient for the model, explaining 
18.5% of the variability (Table  1). Although the remain-
ing variables increase the explained proportion of meth-
ylation variability, they also increase the noise level and 
therefore do not statistically improve the model. We also 
tested other regression modelling approaches not requir-
ing the linear relationships, such as polynomial regres-
sion; however, the fit of the models was not improved.
Discussion
DNA methylation in the mouse oocyte depends upon 
DNMT3A and DNMT3L is primarily over gene bodies 
and largely determined by transcription, but these global 
dependencies could obscure sequence-specific require-
ments or the involvement of additional factors at specific 
elements. By capturing oocytes in the mid-phase of de 
novo methylation, we find that all sequence features gain 
CpG methylation at similar rates overall, including most 
classes of TEs, suggesting a universal rather than a fea-
ture-specific targeting mechanism. CGIs as a whole and a 
subset of L1 elements gain methylation later, however. In 
relation to CGIs, this relative delay might reflect that they 
are marked by default with histone modifications antag-
onistic to DNA methylation, such as H3K4me2/me3, 
and younger L1 elements may be suppressed by histone 
modifications inhibitory to DNA methylation. Amongst 
CGIs, however, there are reproducible differences in time 
of onset and/or progression in de novo methylation. This 
finding, at the genome-wide scale, substantially extends 
earlier studies on limited numbers of imprinted gDMRs 
[12–14] and suggests that CGIs destined for methyla-
tion initially exist in different states of permissiveness. 
There are a number of factors that could contribute to 
this asynchrony. Nuclear availability of DNMT3A [34] 
and DNMT3L is an absolute requirement, and DNMT3L 
is potently up-regulated during oocyte growth. A study 
in which DNMT3A2 and DNMT3L were precociously 
expressed in oocytes was not able to induce methylation 
of imprinted gDMRs in NGOs however, but did advance 
methylation of some gDMRs in growing oocytes [30], 
indicating that some loci are in a state permissive for 
methylation earlier than others.
Having established a major role for transcription in 
conferring the DNA methylation landscape of the oocyte, 
including at CGIs [5–7], we reasoned that timing of tran-
scription events could influence timing of methylation. 
In fact, we did not find strong evidence to support this 
proposition. Despite substantial transcriptional changes 
during initial stages of oocyte growth, most changes 
occur well in advance of the onset of methylation, indi-
cating that remodelling of the oocyte transcriptome is 
not a rate-limiting step in determining permissiveness of 
individual loci. We did find a positive correlation between 
expression and methylation however, so more highly 
expressed gene bodies on average gain methylation ear-
lier than less highly expressed genes; this effect could be 
mediated through transcription-depending chromatin 
remodelling, including deposition of H3K36me3, whose 
levels over gene bodies scale with expression in oocytes 
[20]. A caveat to our analysis is that we used transcript 
abundance as measured by RNA-seq as a proxy for 
transcription, rather than directly determining active 
transcription events. This is because methods have not 
been developed to allow nascent transcription (such as 
by NET-seq) to be mapped in small numbers of cells. 
However, at the very least, the RNA-seq data allow us to 
determine the time that genes are first transcribed during 
oocyte growth.
To explain the difference in onset of methylation at 
CGIs, we considered the contributions of up to nine 
variables for which data were available. In combination, 
these variables explain about a fifth of the variation in 
timing of methylation establishment, with chromatin 
factors—H3K4me2 enrichment, KDM1A dependence 
and KDM1B dependence—having the greatest individual 
effects. There may be several reasons that we are not able 
to account for more of the variation at this time, apart 
from unknown factors not included in the modelling. 
One reason might be the relative imprecision in some 
of the data types; for example, low-cell ChIP-seq data 
for histone modifications in growing oocytes are inher-
ently noisy, being at the limits of the capability of this 
method, and will have missing values at some CGIs. In 
comparison, PBAT data from Kdm1a- and Kdm1b-null 
MII oocytes are likely to be more precise. Therefore, it 
is reassuring that the magnitude of the individual effects 
of H3K4me2 enrichment and KDM1B dependence is 
so similar, since these are likely to be partially depend-
ent variables given that we previously concluded that 
KDM1B is the major locus-specific H3K4me2 dem-
ethylase in oocytes [20]. It was previously suggested 
that KDM1B may be required to allow methylation of 
imprinted gDMRs that acquire methylation late in oocyte 
growth [21]; our genome-wide analysis and modelling 
partly support this earlier inference.
Gross sequence composition accounts for little of the 
variation in CGI methylation timing. Although CpG den-
sity is a determinant of H3K4me2 enrichment at CGIs, 
CGIs destined for methylation in oocytes are relatively 
depleted of H3K4me2 irrespective of CpG density [20]. 
Several sequence motifs, however, were differentially rep-
resented in early- and late-methylating CGIs. Individually, 
these motifs are not as discriminating as the ZFP57 bind-
ing site in imprinted gDMRs [35] that ensures retention 
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of methylation after fertilisation, or the E2F1/E2F2 motif 
enriched in CGIs that escape DNA methylation in oocytes 
[31]. When combined, the three motifs for known TFs 
explain about half as much of the variation in methylation 
onset as do each of the chromatin factors. These motifs 
correspond to binding sites for 15 TFs expressed at vary-
ing levels in oocytes. Although some of their transcripts 
are down-regulated during oocyte growth (Additional 
file 9: Table S8), it is not possible at this stage to conclude 
whether the dynamics of any of these TFs underlies the 
differential methylation onset of the CGIs.
By capturing the progression of methylation, we also 
reveal other important aspects of de novo methylation 
in an in  vivo setting, extending the significance of stud-
ies done in models such as ESCs. For example, we identify 
a co-operativity and nucleosomal pattern of DNMT3A 
action similar to that observed in ESCs [28]. Non-CpG 
methylation has been described as a property of oocytes 
as well as other non-dividing cells [11, 29, 36], but remains 
an enigmatic modification. Even in oocytes, in which 
methylation globally at CHG and CHH sites exceeds that 
at CG sites, few non-CpG sites are methylated (genome-
wide average methylation of CHGs is 3.9%, and CHHs 
are 3.0% compared with 38.7% at CG sites as quantified 
with our parameters using published data [11]), with sites 
methylated mostly only to intermediate levels; moreo-
ver, CHH/CHG methylation is highly associated with 
domains of CpG methylation. Combined with its very 
much later onset, this suggests that CHG/CHH methyla-
tion is largely a by-product of sustained DNMT3A activ-
ity. Finally, DNA methylated domains not associated with 
transcribed regions are also late in acquiring methylation, 
suggesting that they require additional remodelling steps 
or a distinct mechanism of de novo methylation.
Conclusions
The mammalian oocyte provides an important model 
to understand DNA methylation mechanisms, because 
an entire methylation landscape is established de novo 
in a non-dividing cell. Epigenetic remodelling events 
culminate in a distinctive DNA methylation landscape, 
including the programmed methylation of a defined set 
of CGIs, mostly associated with transcription units. 
Despite the simplicity of the methylation landscape, vari-
ous sequence elements are not co-ordinately methylated, 
with pronounced asynchrony in methylation of CGIs. In 
this study, we generated methylation and transcriptome 
data sets to test whether timing of transcription events 
explained asynchrony of CGI methylation; however, our 
results do not support transcriptional transitions as a 
major factor in time of onset of methylation. By incor-
porating data on chromatin state, TF binding motifs 
and the effect of deficiency in H3K4 demethylases, we 
could account for a substantial fraction of variation in 
CGI methylation timing, suggesting that sequences least 
dependent on chromatin remodelling are the earliest to 
become permissive for methylation.
Methods
Isolation and size selection of growing oocytes
Oocytes were collected from C57BL/6Babr mice. Ova-
ries were removed and digested for 30  min at 37  °C in 
1× PBS containing 2 mg/ml collagenase (Sigma-Aldrich, 
C2674) and 0.025% trypsin (Sigma-Aldrich, 93615). M2 
medium (Sigma-Aldrich, M7167) was added to dilute the 
digestion mix, and oocytes were picked up with a mouth-
controlled drawn-out glass pipette. To eliminate contam-
inating somatic cells, oocytes were washed extensively 
in clean drops of M2 medium. A stage micrometre was 
used in combination with an eyepiece reticle to measure 
sizes of oocytes. Mice of post-natal days p5–7, p7–12, 
p9–14 and p13–16 were used to collect oocytes of 10–30, 
40–45, 50–55 and 60–65  µm in diameter, respectively; 
GV oocytes were collected at p20.
Generation of PBAT and RRBS libraries
RRBS libraries were generated, in duplicate, from ~450 
to 550 oocytes per size-selected population, as previously 
described [7], but without the gel-extraction step. Briefly, 
DNA was spiked with a small amount of lambda DNA 
(0.05 pg per 6 ng genomic DNA) for bisulphite conversion 
control, digested with MspI (Thermo Fisher Scientific, 
ER0541), end-repaired (Klenow fragment exo-, Thermo 
Fisher Scientific, EP0421, with 10 nM dATP, 1 nM dCTP 
and 1  nM dGTP) and ligated with 5mC-adapters (Illu-
mina) with T4 ligase (Thermo Fisher Scientific, EL0014). 
Bisulphite conversion was done using the EZ DNA 
Methylation-Direct Kit (Zymo Research, D5020), and 
DNA was amplified by 18 cycles of PCR using PfuTurbo 
Cx Hotstart DNA polymerase (Agilent, 600410). Librar-
ies were purified using SPRI beads (Agencourt, A63880) 
and sequenced 40 bp single end on an Illumina Genome 
Analyzer IIx. The PBAT library was constructed from 
200 60–65  µm oocytes as previously described [20] and 
sequenced 100 bp paired end on an Illumina HiSeq 1000.
Generation of strand‑specific RNA‑seq libraries
Strand-specific RNA-seq libraries were generated as pre-
viously described [6] and sequenced 100  bp paired end 
on an Illumina HiSeq 1000. The numbers of oocytes used 
per library are listed in Additional file 5: Table S4.
Conventional bisulphite sequencing
Bisulphite sequencing was performed essentially as 
previously described [29] using DNA from ~100 to 
200 oocytes plus 50  ng lambda DNA spike-in for each 
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bisulphite conversion using the EZ DNA Methylation 
Kit (Zymo Research, D5001). Bisulphite-converted DNA 
from >30 oocytes was used for each PCR amplification; 
primers are listed in Additional file  10: Table S9. PCR 
products were cloned using pGEM-T Easy Vector Sys-
tems (Promega, A1360) and sequenced with the univer-
sal M13 primer. Experiments were done in duplicate for 
each size group and results combined.
Mapping sequence reads
RRBS reads were trimmed to remove poor quality calls 
and adapters using Trim Galore v0.3.5 (parameters –
rrbs) and mapped to the mouse genome GRCm38 assem-
bly by Bismark [37] v0.14.0 (options –phred64-quals). 
For PBAT data, trimmed reads (Trim Galore v0.3.5 using 
default parameters) were first aligned to GRCm38 in 
paired-end mode to count overlapping parts of the reads 
only once while writing out unmapped singleton reads; in 
a second step remaining singleton reads were aligned in 
single-end mode. Alignments were carried out with Bis-
mark v0.10.0 with the following parameters: –pbat for 
paired-end mode, –pbat for single-end mode for read 1 
and default parameters for single-end mode read 2. Reads 
were then deduplicated with Bismark selecting a random 
alignment for positions covered more than once. CG, 
CHH and CHG methylation calls were extracted using 
the Bismark methylation extractor (v0.10.0) with the 
parameters: –no_overlap –report –ignore 4 –ignore_r2 
4 for paired-end mode and –report –ignore 4 for the 
single-end mode. Published bisulphite-sequencing data 
were processed as described previously [6]. Raw RNA-
seq reads were trimmed to remove poor quality calls 
and adapters using TrimGalore v.0.2.8 and mapped to 
GRCm38 using TopHat v.2.0.9 (option –g 1).
Data analysis and modelling
We used reference and oocyte transcriptomes defined 
previously [6], including the definition of novel genes and 
novel TSSs of known genes, coordinates of CGIs, imprinted 
gDMRs, TEs and methylation domains. CGIs and TEs were 
used for methylation analyses if the minimum number of 
reads to count a position/minimum number of positions to 
count a probe were 5/5 for CGIs, 5/3 for all TEs and 3/3 if 
only methylated or unmethylated TEs were analysed. Oth-
erwise, informative Cs refers to one covered by a minimum 
of 5 reads. Concordance of methylation of adjacent CpGs 
was quantified using custom Perl scripts, using CpGs with 
≥5 reads. Expression of transcripts was quantified using 
Cufflinks v2.1.1 with –G option. Expression of genes was 
determined as a sum of FPKM values of all transcripts per 
gene. Expression of upstream TSSs and FPKM cut-off val-
ues to discriminate expressed and silent transcripts was 
defined as previously [6]. A gene was classified as expressed 
if at least one of its isoforms was classified as expressed. 
A gene/TSS was classified as activated at a specific stage 
if it was classified as expressed in both replicates of that 
stage, as silent in both replicates in previous stages and as 
expressed in both replicates in subsequent stages. DNA 
methylation, RNA-seq and ChIP-seq data were analysed 
using SeqMonk v0.29.0–0.34.0. PC analysis and statistical 
analyses were performed in R v.3.0.2. Motif enrichment 
analysis was performed using DREME [32] and MEME [33] 
within the MEME suite v4.11.1 with default parameters 
specifying list of control sequences. Enriched motifs were 
directly submitted to Tomtom [38] within the MEME suite 
using default parameters. Regression modelling the rela-
tionship between CGI methylation in 60–65  µm oocytes 
and the variables listed in Table  1 was performed in R 
v.3.0.2 using CGIs with all information available. Function 
lm was used for linear regression, package glmnet for Lasso, 
Ridge and ElasiticNet regression, including cross-validation 
of models. Values of response and independent variables 
were normalised to mean 0 and standard deviation 1. GO 
analysis was performed using GOrilla [39] with specifying 
all genes expressed in the oocytes as a background.
Additional files
Additional file 1: Table S1. Sequencing statistics for PBAT and RRBS 
libraries from size‑selected oocytes.
Additional file 2: Table S2. Methylation levels of all CpGs and vari‑
ous genomic features that become methylated in GV oocytes in NGO, 
60–65 µm and GV oocytes.
Additional file 3: Figure S1. Progression of DNA methylation at 
transposable elements (TEs) during oocyte growth, complements Fig. 1. 
Figure S2: Methylation parameters in 60–65 µm oocytes, including 
comparison of PBAT and RRBS data sets. Figure S3. PCA plots for oocyte 
mRNA‑seq libraries. Figure S4. Differentially expressed genes between 
consecutive oocyte size populations. Figure S5. GO analysis of genes 
up‑regulated >50‑fold between e18.5 and GV oocytes. Figure S6. Graph 
showing expression levels over oocyte growth of transcripts for Dnmts, 
Kdm1s and Kdm5s, and SetD2. Figure S7. Methylation level of intragenic 
CGIs in RRBS datasets in relation to expression level of the corresponding 
gene. Figure S8. MEME output of search for motifs enriched in late‑
methylated CGIs.
Additional file 4: Table S3. CG, CHG and CHH methylation levels in 
NGO, 60–65 µm and GV oocytes.
Additional file 5: Table S4. Sequencing statistics for ssRNA‑seq libraries 
from NGO, size‑selected and GV oocytes.
Additional file 6: Table S5. Numbers of genes detected in ssRNA‑seq 
libraries.
Additional file 7: Table S6. Genes up‑regulated ≥50 from e18.5 to 
10–30 µm oocytes and from E18.5 to GV oocytes.
Additional file 8: Table S7. Output from DREME analysis of sequence 
motifs differentially represented in early‑ and late‑methylating CpG 
islands.
Additional file 9: Table S8. Expression levels of transcription factors with 
binding motifs enriched in CGIs with low methylation level in 60–65 µm 
oocytes.
Additional file 10: Table S9. PCR primers sequences for conventional 
bisulphite sequencing of selected CGIs.
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ferase 3A, 3B or 3L; DREME: discriminative regular expression motif elicitation; 
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ily; LINE: long interspersed nuclear element; LTR: long‑terminal repeat; MII: 
metaphase II; MEME: multiple expectation maximisation (EM) for motif elicita‑
tion; NET‑seq: native elongating transcript sequencing; NGO: non‑growing 
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OOEP: oocyte‑expressed protein; Oosp1: oocyte‑specific protein 1, gene; P10: 
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tagging; RRBS: reduced representation bisulphite sequencing; RNA‑seq: RNA 
sequencing; SEBOX: skin–embryo–brain–oocyte‑specific homeobox; SETD2: 
SET domain‑containing 2; SINE: short interspersed nuclear element; TE: trans‑
posable element; TF: transcription factor; TLE6: transducing‑like enhancer of 
split; TSS: transcription start site; Zac1: zinc finger protein regulating apoptosis 
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lucida glycoprotein 1, 2 or 3.
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